Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients.

Soares, Nelson C; Hussein, Amal; Muhammad, Jibran Sualeh; Semreen, Mohammad H; ElGhazali, Gehad; Hamad, Mawieh

Soares, Nelson C; Hussein, Amal; Muhammad, Jibran Sualeh; Semreen, Mohammad H; ElGhazali, Gehad; Hamad, Mawieh.

Affiliation

Soares NC; University of Sharjah, Research Institute of Medical and Health Sciences, Sharjah, United Arab Emirates.
Hussein A; Department of Medicinal Chemistry University of Sharjah, Department of Medicinal Chemistry, College of Pharmacy, Sharjah, United Arab Emirates.
Muhammad JS; Department of Family and Community Medicine & Behavioral Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Semreen MH; University of Sharjah, Research Institute of Medical and Health Sciences, Sharjah, United Arab Emirates.
ElGhazali G; Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Hamad M; University of Sharjah, Research Institute of Medical and Health Sciences, Sharjah, United Arab Emirates.

PLoS One ; 18(8): e0289738, 2023.

Article de En | MEDLINE | ID: mdl-37561777

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limites: Humans Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2023 Type de document: Article Pays d'affiliation: Émirats arabes unis Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google